Fourteen RCTs (n=3,199) were included in the review. Six of the included studies were only reported as abstracts.
The included studies ranged in quality from a score of 0.26 to 0.60, on a scale from 0 to 1.
There was no statistically significant difference in eradication rate between omeprazole and lansoprazole (6 studies; ITT: OR 0.91, 95% CI: 0.69, 1.21). There was no evidence of significant heterogeneity.
There was no statistically significant difference in eradication rate between omeprazole and rabeprazole (4 studies; ITT: OR 0.81, 95% CI: 0.58, 1.15). There was no evidence of significant heterogeneity.
There was no statistically significant difference in eradication rate between omeprazole and esomeprazole (2 studies; ITT: OR 0.89, 95% CI: 0.58, 1.35). There was no evidence of significant heterogeneity.
There was no statistically significant difference in eradication rate between lansoprazole and rabeprazole (3 studies; ITT: OR 0.77, 95% CI: 0.48, 1.22). There was no evidence of significant heterogeneity.